Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Evaluation of the Effects of Sodium–Glucose Co-Transporter 2 Inhibition with Empagliflozin on Morbidity and Mortality in Patients with Chronic Heart Failure and a Preserved Ejection Fraction: Rationale for and Design of the EMPEROR-Preserved Trial

PaperCitations, authors & open-access status

Evaluation of the Effects of Sodium–Glucose Co-Transporter 2 Inhibition with Empagliflozin on Morbidity and Mortality in Patients with Chronic Heart Failure and a Preserved Ejection Fraction: Rationale for and Design of the EMPEROR-Preserved Trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 252 citations, 2019 year and hybrid oa status.

252
Citations
2019
Year
hybrid
OA Status

Related on ScholarIQ

Stefan D. Anker
Author
Jyothis T. George
Author
Javed Butler
Author
Gerasimos Filippatos
Author
Faı̈ez Zannad
Author
Milton Packer
Author
470M+ articles · free account